N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-2-phenyl-acetamide hydrochloride | 405166-84-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-2-phenyl-acetamide hydrochloride
• 英文别名: N-[2-[3-[(dimethylamino)methyl]-6-methoxy-1-oxo-4-phenylisoquinolin-2-yl]ethyl]-2-phenylacetamide;hydrochloride
• CAS: 405166-84-9
• 化学式: C₂₉H₃₁N₃O₃*ClH
• 分子量: 506.044
• InChiKey: STCGIXTWAZVEQS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.52
• 重原子数：
  36
• 可旋转键数：
  9
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  61.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-methanesulfonamide 、 butane-1-sulfonic acid [2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-amide 、 thiophene-2-sulfonic acid [2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-amide 、 N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-benzenesulfonamide 、 furan-2-carboxylic acid [2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-amide 、 N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-2-phenyl-acetamide hydrochloride 、 N-[2-(3-dimethylaminomethyl-6-methoxy-1-oxo-4-phenyl-1H-isoquinolin-2-yl)-ethyl]-nicotinamide 生成 2-(5-methoxy-2-methyl-1H-indol-3-yl)-N-(6-methoxy-2-methyl-1-oxo-4-phenyl-1,2-dihydro-isoquinolin-3-ylmethyl)-acetamide
  参考文献：
  名称：

  Isoquinolinone potassium channels inhibitors

  摘要：

  本发明涉及某些异喹啉酮化合物及其作为电压依赖性钾通道或电流的抑制剂的用途，例如Kv1.5和IKur，这些通道或电流可作为治疗心律失常特别是心房心律失常的靶点。本发明还提供了一种治疗或预防对钾通道或电流的抑制有反应的病症的方法，例如心律失常，特别是心房心律失常。本发明还包括制药配方和制药组合物的制备方法，其中包括某些异喹啉酮化合物或其药学上可接受的盐、水合物、溶剂合物、晶体形式和立体异构体，以及药学上可接受的载体。

  公开号：

  US20040044030A1

文献信息

• ISOQUINOLINONE POTASSIUM CHANNEL INHIBITORS
  申请人：Merck & Co., Inc.

  公开号：EP1322619B1

  公开（公告）日：2008-01-23
• EP1322619A4
  申请人：——

  公开号：EP1322619A4

  公开（公告）日：2004-02-25
• US6870055B2
  申请人：——

  公开号：US6870055B2

  公开（公告）日：2005-03-22
• [EN] ISOQUINOLINONE POTASSIUM CHANNEL INHIBITORS<br/>[FR] ISOQUINOLINONE EN TANT QU'INHIBITEURS DU CANAL POTASSIQUE
  申请人：MERCK & CO INC

  公开号：WO2002024655A1

  公开（公告）日：2002-03-28

  The present invention concerns certain isoquinolinone compounds and their utility as inhibitors of voltage-dependent potassium channels or currents, such as Kv1.5 and IKur, that could serve as targets for the treatment of cardiac arrhythmias especially atrial arrhythmias. The present invention also provide a method for treating or preventing conditions which respond to the inhibition of potassium channels or currents, such as cardiac arrhythmias and more especially atrial arrhythmias. The present invention further includes pharmaceutical formulations and a process of making a pharmaceutical composition comprising a compound of certain isoquinolinone or its pharmaceutically acceptable salts, hydrates, solvates, crystal forms, and stereoisomers thereof, and a pharmaceutically acceptable carrier.